stockrowThe Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
- Revenue
- +33.3%
- EPS
- +118.9%
- Free cash flow
- +84.2%
- Total debt
- +60.3%
Quarter to September 2026, against a year earlier
Follow CLX
Alert me
The Clorox Company (CLX) EBITDA
The Clorox Company's EBITDA for fiscal 2026 was $1.2B, down 10.7% from $1.3B in fiscal 2025. Over the twelve months to 30 September 2026 it was $1.3B. Over the past ten years it has ranged from $747.0M (fiscal 2024) to $1.5B (fiscal 2021); the current reading is higher than 33% of that period. The Clorox Company ranks 7th of 28 Household & Personal Products companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $1.2B | (10.70%) |
| FY2025 | $1.3B | 73.90% |
| FY2024 | $747.0M | (31.40%) |
| FY2023 | $1.1B | 11.81% |
| FY2022 | $974.0M | (33.61%) |
| FY2021 | $1.5B | 0.89% |
| FY2020 | $1.5B | 11.50% |
| FY2019 | $1.3B | 0.15% |
| FY2018 | $1.3B | 0.93% |
| FY2017 | $1.3B | 4.96% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $335.0M | (0.30%) |
| Jun 2026 | $336.0M | (3.17%) |
| Mar 2026 | $347.0M | 17.23% |
| Dec 2025 | $296.0M | 63.54% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| KMB Kimberly-Clark Corporation compare | $3.2B |
| EL The Estee Lauder Companies Inc. compare | $1.8B |
| CHD Church & Dwight Co., Inc. compare | $1.4B |
| CLX The Clorox Company | $1.3B |
| NWL Newell Brands Inc. compare | $833.0M |
| COTY Coty compare | $378.5M |
| SPB Spectrum Brands Holdings Inc. compare | $306.8M |
| IPAR Interparfums, Inc. compare | $292.6M |
| ELF e.l.f. Beauty compare | $221.4M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CLX
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement